6 results on '"OCT-A"'
Search Results
2. Review of the Current Literature and Our Experience on the Value of OCT-angiography in White Dot Syndromes.
- Author
-
Mebsout-Pallado C, Orès R, Terrada C, Dansingani KK, Chhablani J, Eller AW, Martel JN, Anetakis A, Harwick JC, Waxman EL, Gallagher DS, Prensky C, Indermill C, Sedira N, Héron E, Paques M, Brignole-Baudouin F, Bodaghi B, Sahel JA, Gaudric A, Mrejen S, and Errera MH
- Subjects
- Birdshot Chorioretinopathy, Choroid, Fluorescein Angiography, Humans, Multifocal Choroiditis, Tomography, Optical Coherence, Choroiditis diagnosis, White Dot Syndromes
- Abstract
Purpose: To describe the application of OCT-A in various posterior uveitis disorders in our experience and to compare it with the available literature., Methods: Eighteen eyes with the diagnoses of multifocal choroiditis (MFC), multifocal placoid pigment epitheliopathy (APMPPE), multiple evanescent white dot syndrome (MEWDS), tuberculous serpiginous-like choroiditis (SLC), serpiginous choroiditis (SC), and birdshot chorioretinopathy (BSCR) were studied., Results: We found flow void of the choriocapillaris in patients with APMPPE, SC, MFC, BSCR, and in SLC. In contrast, perfusion of the choriocapillaris seemed normal in patients with MEWDS., Conclusions: We confirmed that OCT-A contributes new information on the physiopathology of white dot syndromes and inflammatory chorioretinopathies, notably on whether or not the choriocapillaris is involved. Comparing the OCT-A features allowed us to suggest that both APMPPE and SLC might be part of the same spectrum of inflammatory disease with primary involvement at the level of the choriocapillaris and secondary RPE damage.
- Published
- 2022
- Full Text
- View/download PDF
3. Optical coherence tomography angiography cyclic remodeling of CNV in patients affected by Best macular dystrophy.
- Author
-
Murro V, Mucciolo DP, Giorgio D, Sodi A, Passerini I, Cipollini F, Virgili G, and Giansanti F
- Subjects
- Adolescent, Child, Choroidal Neovascularization diagnostic imaging, Choroidal Neovascularization drug therapy, Female, Humans, Male, Retrospective Studies, Visual Acuity, Vitelliform Macular Dystrophy physiopathology, Choroidal Neovascularization pathology, Fluorescein Angiography methods, Photochemotherapy methods, Tomography, Optical Coherence methods, Vitelliform Macular Dystrophy drug therapy
- Abstract
Purpose: To evaluate the effect of photodynamic therapy and/or intravitreal injections on choroidal neovascularization in treatment-naïve patients affected by Best Macular Dystrophy using OCT-A., Materials and Methods: BMD patients with CNV treated using PDT and/or IV were included in the study. All patients underwent a complete ophthalmological examination, OCT and 3 × 3 mm OCT-A. The OCT-A images were analyzed using an open-source software (ImageJ) to assess the CNV membrane area (CNV-MA), the CNV vessel area (CNV-VA), and vessel density (VD) at the follow-ups (3 months after PDT and 1 month after IV)., Results: Five eyes of four patients with CNV were included. All eyes received PDT as first-line therapy; 4 eyes underwent more than 1 treatment session: three eyes received 1 IV, whereas one eye had one further PDT. After PDT, the CNV-MA, CNV-VA, and VD quantitative parameters were obtained for four out of five eyes: in three eyes of two patients CNV-MA, CNV-VA, and VD first decreased and then gradually increased during follow-up, whereas in one eye of one patient CNV-MA, CNV-VA, and VD slightly increased. After IV the CNV-MA, CNV-VA, and VD had significantly decreased at the 1-month follow-up in three eyes of three patients., Conclusion: OCT-A is an important tool for the diagnosis of both naïve and fibrotic CNV in BMD patients; it is a non-invasive method for the qualitative and quantitative analysis of neovascular lesions during follow-up. Our results have shown a cyclic remodeling of treated CNV in BMD patients using both PDT and IV.
- Published
- 2020
- Full Text
- View/download PDF
4. Optical Coherence Tomography Angiography (OCT-A) in Choroideremia (CHM) carriers.
- Author
-
Murro V, Mucciolo DP, Giorgio D, Sodi A, Passerini I, Virgili G, and Rizzo S
- Subjects
- Adolescent, Adult, Case-Control Studies, Choroideremia diagnostic imaging, Female, Humans, Male, Middle Aged, Young Adult, Choroideremia pathology, Fluorescein Angiography methods, Image Processing, Computer-Assisted methods, Tomography, Optical Coherence methods
- Abstract
Purposes : To explore OCT-A abnormalities in CHM carriers Methods : CHM carriers and age-matched controls were consecutively enrolled at the Eye Clinic in Florence. All patients underwent a complete ophthalmic examination, fundus photography, fundus autofluorescence (FAF) and OCT examinations. OCT-A images of the superficial capillary plexus (SCP), deep capillary plexus (DCP) and choriocapillaris slab (CC) were acquired and analyzed using ImageJ software to detect and quantify vascular density. Results : Six patients (12 eyes) and 8 age-matched controls (16 eyes) were included in our study. The mean age was 45.5 ± 16.3 years (range 15-61) for the CHM carriers and 46.6 ± 12.2 (range 18-54) for controls. All CHM carriers showed fundus abnormalities. The detected mean central retinal thickness (CRT) (220 ± 18.34 vs 227 ± 15.46; p = .342) and choroidal central thickness (CCT) (271 ± 54.28 vs 275 ± 38.36; p = .760) did not differ between the carrier and the control group, respectively. Quantitative analysis of the inner retinal vasculature disclosed no significant difference of both SCP ( p = .437) and DCP ( p = .859) vessel density compared to the control group. Of note, a mild reduction on the vascular flow of the CC could be detected in the carrier group compared to the control group (78.896 ± 13.972 vs 80.008 ± 10.862; p = .045). Conclusions : OCT-A allows us to underline the role of the retinal pigment epithelium in the CHM pathophysiology. Central inner retinal and choriocapillaris vascularization were preserved although the RPE was always involved in the CHM carrier: this could support a secondary role of vascular impairment in the natural history of the disease.
- Published
- 2020
- Full Text
- View/download PDF
5. Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy.
- Author
-
Cui X, Jauregui R, Park KS, and Tsang SH
- Subjects
- Aged, Female, Fluorescein Angiography, Genotype, Gyrate Atrophy diagnosis, Humans, Multimodal Imaging, Pedigree, Tomography, Optical Coherence, Gyrate Atrophy drug therapy, Gyrate Atrophy genetics, Mutation, Missense, Ornithine-Oxo-Acid Transaminase genetics, Vitamin B 6 therapeutic use, Vitamin B Complex therapeutic use
- Abstract
Purpose: Gyrate atrophy (GA) is a rare chorioretinal degeneration that results in the deterioration of night and peripheral vision, eventually leading to blindness. The disorder is caused by mutations in the gene encoding ornithine aminotransferase (OAT), causing increased levels of plasma ornithine. Treatment revolves around lowering plasma ornithine levels, with vitamin B6 supplementation being the preferred treatment. Nevertheless, most patients do not respond to this therapy. Here, we report a rare case of vitamin B6-responsive GA caused by a novel mutation in OAT and characterize the presentation with multimodal imaging., Methods: This is a single-patient case report with a clinical diagnosis based on history, multimodal retinal imaging, laboratory findings, and DNA sequencing analysis. We include a 3D structure prediction of the novel mutant protein., Results: DNA sequencing analysis demonstrated that there is a homozygous, novel variant c.473A>C: p.Y158S in OAT. Upon undergoing two weeks of vitamin B6 supplementation, the patient exhibited a 28.5% reduction in plasma ornithine levels. In a follow-up visit two years later, plasma ornithine levels were reduced by 24.1% from the levels at initial presentation and disease progression was retarded based on clinical findings., Conclusion: One novel homozygous missense mutation in OAT was identified and considered to be pathogenic in a patient with GA. The response for the vitamin B6 supplementation was positive, which is rare in all the GA cases reported in the literature. Our data suggests that further studies regarding the relationship between genotype and responsiveness to vitamin B6 should be conducted.
- Published
- 2018
- Full Text
- View/download PDF
6. OCT-Angiography for monitoring and managing neovascular age-related macular degeneration.
- Author
-
Malamos P, Tsolkas G, Kanakis M, Mylonas G, Karatzenis D, Oikonomopoulos N, Lakoumentas J, and Georgalas I
- Subjects
- Aged, Angiogenesis Inhibitors therapeutic use, Choroidal Neovascularization drug therapy, Coloring Agents administration & dosage, Female, Humans, Indocyanine Green administration & dosage, Male, Middle Aged, Multimodal Imaging, Prospective Studies, Sensitivity and Specificity, Vascular Endothelial Growth Factor A antagonists & inhibitors, Visual Acuity physiology, Wet Macular Degeneration drug therapy, Choroidal Neovascularization diagnosis, Fluorescein Angiography, Tomography, Optical Coherence, Wet Macular Degeneration diagnosis
- Abstract
Purpose: To evaluate the combined use of optical coherence tomography and angiography (OCT-A) for imaging choroidal neovascularization (CNV) secondary to neovascular age-related macular degeneration (nAMD)., Materials and Methods: This prospective observational study was conducted from May 2015 to April 2017. Included in the study were 54 patients (n = 63 eyes), all of whom had CNV secondary to nAMD and all of whom had been examined by OCT-A. Angioscans (3x3 and 6 × 6) and conventional B-scan OCT scans were obtained for all patients at baseline and at various times during the 24-month follow-up period. For diagnostic confirmation, conventional imaging methods fluorescein angiography (FA) and indocyanine green angiography (ICGA) were performed at baseline. A total of 13 patients (n = 15 eyes) underwent serial imaging during 34 follow-up visits. The main outcomes included (i) determination of OCT-A sensitivity for the detection of CNV (classic and occult) and (ii) the correlation between B-scan OCT and OCT-A vis-à-vis consecutive follow-up changes., Results: At baseline, the detection rate (i.e., overall sensitivity) of OCT-A for detecting CNV was 64.4% (75.7 and 48.0% for classic and occult CNV, respectively), independent of prior treatment status. In terms of quality, 6 × 6 angioscans were superior to 3 × 3. Moreover, specific CNV morphologic patterns by B-scan OCT did not correlate with lesion composition. Correspondence between OCT-A and B-scan OCT was observed in only 53% of the cases., Conclusions: OCT-A may prove to be a valuable adjunctive diagnostic tool for the interpretation of CNV, as it not only reduces the need for invasive angiographic procedures but also facilitates the follow-up process.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.